IMMUNOCORE HOLDINGS PLC - AMERICAN DEPOSITARY SHAR

Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO

03 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

01 Jun 2023 16:30:00 By Nasdaq GlobeNewswire

Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update

10 May 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore to present at the Bank of America Securities 2023 Health Care Conference

03 May 2023 16:30:00 By Nasdaq GlobeNewswire

Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival

18 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference

11 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore to present four posters at AACR Annual Meeting 2023

14 Mar 2023 16:30:00 By Nasdaq GlobeNewswire

Immunocore Reports 2022 Financial Results and Provides Business Update

01 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023

23 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV

22 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

01 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore announces strategic priorities including pipeline expansion for 2023 -2024

09 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference

04 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Immunocore is awarded the Prix Galien France award for KIMMTRAK

15 Dec 2022 06:00:00 By Nasdaq GlobeNewswire

Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4

08 Dec 2022 06:30:00 By Nasdaq GlobeNewswire

Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors

02 Dec 2022 07:30:00 By Nasdaq GlobeNewswire

Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference

23 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting

11 Nov 2022 09:00:00 By Nasdaq GlobeNewswire

Immunocore to present at the Jefferies London Healthcare Conference

10 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

Immunocore Reports Third Quarter 2022 Financial Results and Provides Business Update

09 Nov 2022 07:00:00 By Nasdaq GlobeNewswire